mRNA flu vaccine mFlusiva faces its FDA decision deadline today. Approval will not automatically trigger insurance coverage ...

"Like a phoenix rising from the ashes, new ways of working in public health are emerging," writes Dr. Debra Houry.

Teknova will continue to expand Build-Tek’s capabilities drawing on 30 years of custom reagent manufacturing experience. Planned enhancements include the ability to customize existing catalog products ...

Agreement provides for up to $17.5 million in additional funding through subsequent tranche closings to support Alzamend's clinical programs and working capital needs ATLANTA, Aug. 4, 2026 /PRNewswire ...

Here’s what we’ve learned – and how our understanding has evolved – since the earliest cases of the novel coronavirus were ...

Guido Oelkers, Ph.D., appointed to BioNTech Management Board as Chief Executive Officer, taking office by February 1, 2027, at the latestAdvanced ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

Allergen immunotherapy (AIT) remains the only disease-modifying treatment for IgE-mediated allergic diseases. While its clinical efficacy has been ...

We heard from five of these students: They are working at a neuroscience lab, a professional group linking climate and public ...

In a discovery that could redefine the future of cancer immunotherapy, scientists from Celloram Inc., University Hospitals ...

The Gates Medical Research Institute (Gates MRI) and Serum Institute of India Private Ltd (SII) have agreed to manufacture M72/AS01E, a novel tuberculosis (TB) vaccine candidate. And SII expects to ...

In the United States, children routinely receive an injectable form of the polio vaccine. This vaccine is very effective at preventing illness, but it doesn't block transmission of the polio virus as ...